Maternal Determinants of Infant Immunity to Pertussis

Clinical trial NCT05856396 · COMPLETED

Trial details

NCT number: NCT05856396
Sponsor: Centre Hospitalier Universitaire Saint Pierre
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Vaccination; Infection Maternal-Fetal Relations Pertussis Immunoglobulins

Start date: 2023-09-12
Primary completion: 2025-12-23
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.